Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy.

Thannickal TC, Siegel JM, Nienhuis R, Moore RY.

Brain Pathol. 2003 Jul;13(3):340-51.

PMID:
12946023
2.

The hypocretin/orexin system in health and disease.

Nishino S.

Biol Psychiatry. 2003 Jul 15;54(2):87-95. Review. Erratum in: Biol Psychiatry. 2003 Jul 15;54(2):175.

PMID:
12873797
3.

Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter.

Baumann CR, Bassetti CL.

Sleep Med Rev. 2005 Aug;9(4):253-68. Review.

PMID:
15979356
4.

Narcolepsy: a neurodegenerative disease of the hypocretin system?

van den Pol AN.

Neuron. 2000 Sep;27(3):415-8. Review. No abstract available.

5.
6.

Narcolepsy and the hypocretins.

Wurtman RJ.

Metabolism. 2006 Oct;55(10 Suppl 2):S36-9. Review.

PMID:
16979425
7.

Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain.

Kornum BR, Faraco J, Mignot E.

Curr Opin Neurobiol. 2011 Dec;21(6):897-903. doi: 10.1016/j.conb.2011.09.003. Review.

PMID:
21963829
8.

Metabolic state signalling through central hypocretin/orexin neurons.

Burdakov D, Alexopoulos H.

J Cell Mol Med. 2005 Oct-Dec;9(4):795-803. Review.

9.

Narcolepsy and the hypocretin system--where motion meets emotion.

Siegel JM, Boehmer LN.

Nat Clin Pract Neurol. 2006 Oct;2(10):548-56. Review.

PMID:
16990828
10.

Cell transplantation: a future therapy for narcolepsy?

Arias-Carrión O, Murillo-Rodríguez E.

CNS Neurol Disord Drug Targets. 2009 Aug;8(4):309-14. Review.

PMID:
19689312
11.

Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis.

Sakurai T.

Sleep Med Rev. 2005 Aug;9(4):231-41. Review.

PMID:
15961331
12.

Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss?

Fontana A, Gast H, Reith W, Recher M, Birchler T, Bassetti CL.

Brain. 2010 May;133(Pt 5):1300-11. doi: 10.1093/brain/awq086. Review.

13.

The hypocretin/orexin receptor: therapeutic prospective in sleep disorders.

Nishino S.

Expert Opin Investig Drugs. 2007 Nov;16(11):1785-97. Review.

PMID:
17970638
14.

Hypocretin/orexin disturbances in neurological disorders.

Fronczek R, Baumann CR, Lammers GJ, Bassetti CL, Overeem S.

Sleep Med Rev. 2009 Feb;13(1):9-22. doi: 10.1016/j.smrv.2008.05.002. Review.

PMID:
18819824
15.

Roles of the hypocretin/orexins in the regulation of sleep and wakefulness.

Terao A, Haruyama T, Kimura K.

Jpn J Vet Res. 2008 Jan;55(2-3):75-83. Review.

PMID:
18318109
16.

Sleep, sleep disorders and hypocretin (orexin).

Mignot E.

Sleep Med. 2004 Jun;5 Suppl 1:S2-8. Review. Erratum in: Sleep Med. 2004 Sep;5(5):515.

PMID:
15301991
17.

The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.

Zeitzer JM, Nishino S, Mignot E.

Trends Pharmacol Sci. 2006 Jul;27(7):368-74. Review.

PMID:
16766052
18.

The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic function.

Ferguson AV, Samson WK.

Front Neuroendocrinol. 2003 Jul;24(3):141-50. Review.

PMID:
14596809
19.

Narcolepsy and the HLA region.

Lin L, Hungs M, Mignot E.

J Neuroimmunol. 2001 Jul 2;117(1-2):9-20. Review.

PMID:
11431000
20.

Coexistence of narcolepsy and Alzheimer's disease.

Scammell TE, Matheson JK, Honda M, Thannickal TC, Siegel JM.

Neurobiol Aging. 2012 Jul;33(7):1318-9. doi: 10.1016/j.neurobiolaging.2010.12.008. Review.

PMID:
21257235
Items per page

Supplemental Content

Support Center